Acumen’s own, Suzanne Hanifin, is moderating a break out session at the next Oregon Bioscience Annual Conference (October 20th & 21st) where panelists will share their experiences and insights regarding Career Progression, Mentoring, and how sometimes life just takes you down unknown/unplanned roads to lead us where we are today.
Suzanne, the Founder & CEO of Acumen Executive & Talent Search will share her story regarding her many career turns. Suzanne is honored to moderate the Professional Development with fabulous panelists: Emmanuel Akporiaye, Ralph Makar, and Tommy Pham. See their bio’s below.
We hope to see you at the Oregon Bioscience Annual Conference on October 19th & 20th, 2016.
Break Out Session – Career Development Panelist:
Emmanuel Akporiaye, Ph.D. Founder and CEO, Veana Therapeutics, Inc.
Dr. Emmanuel Akporiaye is Founder and CEO of Veana Therapeutics, Inc., a biotechnology company founded in 2012 as a spin-off from the Earle A. Chiles Research Institute of the Providence Cancer Center in Portland, Oregon. Until recently, Dr. Akporiaye was Division Chief of Experimental Biology and Scientific Career Development at Sidra Medical and Research Center, Doha, Qatar. Prior to joining Sidra, Dr. Akporiaye was Chief of the Laboratory of Tumor Immunology and Therapeutics at the Earle A. Chiles Research Institute where he led the discovery, development and production of a novel anti-cancer agent that is in a first-in-human clinical trial at Providence Portland Medical Center. Dr. Akporiaye is a Fulbright Senior Scholar and Professor Emeritus from the University of Arizona. He currently holds the position of Adjunct Full Member at the Earle A. Chiles Research Institute where he continues to oversee the management of the ongoing Phase I clinical trial.
Ralph Makar President and CEO
Ralph Makar is a successful Life Sciences executive with both US and Global experience in strategic leadership, business development and general management, as well as raising capital for both startup and established organizations. Ralph is currently engaged as an Executive and Board Level Advisor providing consulting services to various life sciences organizations. Mr. Makar is on the Board of the Oregon Bioscience Organization and Mesa Therapeutics, and also serves as an Advisor to a number of other firms. He most recently served as President and Chief Executive Officer (CEO) for Azure Biotech Inc. Prior to that, Mr. Makar was President and CEO for Bioject Medical Technologies Inc., a public company. In addition to working with startups, Ralph also has significant large Pharma experience, having served as Vice President and General Manager of the Therapeutics Business Unit at Berlex Labs (currently part of Bayer HealthCare). Mr. Makar’s 25+ years of industry experience has included roles of increasing responsibility at Novartis, Parke Davis and Schering AG. He has a BS in Pharmacy from the Ernest Mario School of Pharmacy at Rutgers University and an MBA from Columbia Business School.
Tommy Pham Patent Liason—Global Innovation, Nike
Tommy Pham was on the pre-med career track, earned his BS in Biology from University of Portland (UP) until a change of heart on the morning of his Medical College Admission Test. Instead, Tommy pursued an MBA and Technology Entrepreneurship Certificate through a joint graduate program between UP and Oregon Health & Science University (OHSU). As a result of the program, which involved analyzing several OHSU technologies for commercial feasibility, Tommy co-founded, Nzumbe, a biotech start-up. Tommy now works for Nike as a Patent Liaison, where he identifies and captures new innovation to create intellectual property assets. Tommy is also a Founding Board Member of the Children’s Cancer Therapy Development Institute.